An Observational Clinical Study on the Construction of an Artificial Neural Network Model for ICU Pneumonia

ConditionPneumonia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese Medical Association

About this trial

To achieve rapid, intelligent and accurate microbiological diagnosis and treatment for ICU pneumonia, an artificial neural network model for microbiological diagnosis is established, which depends on many clinical cases and machine deep learning from clinical experts' judgements according to species-specific rapid detection of pathogenic bacteria and other clinical parameter variables of patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

aged ≥18 years;

agreed to obtain lower respiratory specimens for rapid testing of pathogenic bacteria;

all were enrolled by an experienced physician who dynamically determined that the microorganisms were in a colonised or infected state;

signed an informed consent form.

Disqualifiers

pregnant women;

lactating women;

patients who could not obtain lower respiratory specimens;

Trial population

Pneumonia patients who admitted to Nanjing Drum Tower Hospital from Jan 1,2025 to Dec 31,2027 and meet the inclusion criteria.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • establish an artificial neural network model

    Other intervention

    to establish an artificial neural network model for pathogen diagnosis in ICU pneumonia

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

clinical evaluation of each microbial detected whether in colonization or infection

Two experienced senior physicians are organized to determine whether the microbial are colonized or infected according to clinical values.

Time frame
day1,day3 and day7 after enrollment

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: